These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Prospective, double blinded, comparative assessment of the pharmacological activity of Cerebrolysin and distinct peptide preparations for the treatment of embolic stroke. Zhang L; Chopp M; Wang C; Zhang Y; Lu M; Zhang T; Zhang ZG J Neurol Sci; 2019 Mar; 398():22-26. PubMed ID: 30665068 [TBL] [Abstract][Full Text] [Related]
23. Early Fiber Number Ratio Is a Surrogate of Corticospinal Tract Integrity and Predicts Motor Recovery After Stroke. Bigourdan A; Munsch F; Coupé P; Guttmann CR; Sagnier S; Renou P; Debruxelles S; Poli M; Dousset V; Sibon I; Tourdias T Stroke; 2016 Apr; 47(4):1053-9. PubMed ID: 26979863 [TBL] [Abstract][Full Text] [Related]
24. Cerebrolysin: a multi-target drug for recovery after stroke. Brainin M Expert Rev Neurother; 2018 Aug; 18(8):681-687. PubMed ID: 30004268 [TBL] [Abstract][Full Text] [Related]
25. Cerebrolysin effects on neurological outcomes and cerebral blood flow in acute ischemic stroke. Amiri-Nikpour MR; Nazarbaghi S; Ahmadi-Salmasi B; Mokari T; Tahamtan U; Rezaei Y Neuropsychiatr Dis Treat; 2014; 10():2299-306. PubMed ID: 25516711 [TBL] [Abstract][Full Text] [Related]
26. Effects of high- and low-frequency repetitive transcranial magnetic stimulation on motor recovery in early stroke patients: Evidence from a randomized controlled trial with clinical, neurophysiological and functional imaging assessments. Du J; Yang F; Hu J; Hu J; Xu Q; Cong N; Zhang Q; Liu L; Mantini D; Zhang Z; Lu G; Liu X Neuroimage Clin; 2019; 21():101620. PubMed ID: 30527907 [TBL] [Abstract][Full Text] [Related]
27. Evaluating the effect and mechanism of upper limb motor function recovery induced by immersive virtual-reality-based rehabilitation for subacute stroke subjects: study protocol for a randomized controlled trial. Huang Q; Wu W; Chen X; Wu B; Wu L; Huang X; Jiang S; Huang L Trials; 2019 Feb; 20(1):104. PubMed ID: 30728055 [TBL] [Abstract][Full Text] [Related]
28. [Possibilities of neurotrophic therapy in early recovery after stroke]. Bogolepova AN Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(8. Vyp. 2):84-89. PubMed ID: 31825367 [TBL] [Abstract][Full Text] [Related]
30. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial. Ladurner G; Kalvach P; Moessler H; J Neural Transm (Vienna); 2005 Mar; 112(3):415-28. PubMed ID: 15583955 [TBL] [Abstract][Full Text] [Related]
31. Effectiveness and neural mechanisms of home-based telerehabilitation in patients with stroke based on fMRI and DTI: A study protocol for a randomized controlled trial. Chen J; Liu M; Sun D; Jin Y; Wang T; Ren C Medicine (Baltimore); 2018 Jan; 97(3):e9605. PubMed ID: 29504985 [TBL] [Abstract][Full Text] [Related]
32. [The effect of cerebrolysin in dosage 50 ml on the volume of lesion in ischemic stroke]. Shamalov NA; Stakhovskaia LV; Burenchev DV; Kichuk IV; Tvorogova TV; Botsina AIu; Smychkov AS; Kerbikov OB; Moessler H; Novak P; Skvortsova VI Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12 Pt 2):34-7. PubMed ID: 21626816 [TBL] [Abstract][Full Text] [Related]
33. [Clinical and pharmacoeconomic peculiarities of the treatment with cerebrolysin in the period of rehabilitation of is ischemic stroke.]. Gusev EI; Gekht AB; Belousov IuB; Pavlov NA; Galanov DV; Popov GR; Mil'chakova LE Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(10):26-33. PubMed ID: 18477976 [TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety comparison of DL-3-n-butylphthalide and Cerebrolysin: Effects on neurological and behavioral outcomes in acute ischemic stroke. Xue LX; Zhang T; Zhao YW; Geng Z; Chen JJ; Chen H Exp Ther Med; 2016 May; 11(5):2015-2020. PubMed ID: 27168844 [TBL] [Abstract][Full Text] [Related]
35. A double-blind, placebo-controlled, multicenter study of Cerebrolysin for Alzheimer's disease. Bae CY; Cho CY; Cho K; Hoon Oh B; Choi KG; Lee HS; Jung SP; Kim DH; Lee S; Choi GD; Cho H; Lee H J Am Geriatr Soc; 2000 Dec; 48(12):1566-71. PubMed ID: 11129744 [TBL] [Abstract][Full Text] [Related]
36. Cost-Effectiveness of Cerebrolysin after Ischemic Stroke: Secondary Analysis of the CARS Study. Strilciuc S; Radu C; Grad DA; Stan AD; Vladescu C; Buzoianu AD; Muresanu D Healthcare (Basel); 2023 May; 11(10):. PubMed ID: 37239783 [TBL] [Abstract][Full Text] [Related]
37. Best conventional therapy versus modular impairment-oriented training for arm paresis after stroke: a single-blind, multicenter randomized controlled trial. Platz T; van Kaick S; Mehrholz J; Leidner O; Eickhof C; Pohl M Neurorehabil Neural Repair; 2009 Sep; 23(7):706-16. PubMed ID: 19541918 [TBL] [Abstract][Full Text] [Related]
38. Effect of NEuroplasticity-Principles-based SEnsory-Rehabilitation (NEPSER) on sensori-motor recovery in stroke: study protocol for a randomized controlled trial. Arya KN; Pandian S; Agarwal GG; Chaudhary N; Joshi AK Neurol Res Pract; 2021 Feb; 3(1):8. PubMed ID: 33536067 [TBL] [Abstract][Full Text] [Related]
39. Effect of Early and Intensive Rehabilitation after Ischemic Stroke on Functional Recovery of the Lower Limbs: A Pilot, Randomized Trial. Wu WX; Zhou CY; Wang ZW; Chen GQ; Chen XL; Jin HM; He DR J Stroke Cerebrovasc Dis; 2020 May; 29(5):104649. PubMed ID: 32115341 [TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of Cerebrolysin in patients with hemorrhagic stroke. Bajenaru O; Tiu C; Moessler H; Antochi F; Muresanu D; Popescu BO; Novak P J Med Life; 2010; 3(2):137-43. PubMed ID: 20968198 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]